Marvell Technology, Inc. Profile Avatar - Palmy Investing

Marvell Technology, Inc.

Marvell Technology, Inc., together with its subsidiaries, designs, develops, and sells analog, mixed-signal, digital signal processing, and embedded and standalone integrated circuits. It offers a portfolio of Ethernet solutions, including controllers, n…
Semiconductors
US, Wilmington [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 67% Positive
Leverage & Liquidity 17% Weak
Per Share Metrics 0% Bad
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 89.22 333.51 176.26
Graham Fair Price -26.82 9.69 13.24
PEG 469.14 1.55 -0.27
Price/Book 3.96 4.09 3.94
Price/Cash Flow 102.97 254.89 125.58
Prices/Earnings -84.85 -68.72 -37.17
Price/Sales 24.71 51.05 40.93
Price/FCF 102.97 254.89 125.58
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -2.34 0.45 0.47
Operating Margin -2328.09 -0.13 < 0.005
ROA 43.12 -0.01 -0.02
ROE -0.03 -0.01 43.76
ROIC < 0.005 < 0.005 -388.82
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ < 0.005 0.12 -91.94
Dividends QOQ < 0.005 < 0.005 -352.08
EBIT QOQ 0.95 -18.76 1877.37
EPS QOQ -1.37 0.44 -67.52
FCF QOQ 0.04 -0.50 1242.22
Revenue QOQ < 0.005 -0.19 3243.41
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 102.04 117.48 15.13
Days Sales Outstanding (DSO) 70.76 68.37 -3.38
Inventory Turnover 0.88 0.77 -13.14
Debt/Capitalization 0.23 0.23 1.16
Quick Ratio 1.14 1.18 3.16
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 17.15 16.74 -2.41
Cash 1.10 0.98 -10.87
Capex -0.09 -0.11 -12.71
Free Cash Flow 0.54 0.27 -50.02
Revenue 1.65 1.34 -18.65
Naive Interpretation member
05 - Per Share Metrics · Bad
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.69 1.80 6.86
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 10.65 20.45 92.03
Naive Interpretation Member
06 - Financial Health · Weak
End of MRVL's Analysis
CIK: 1835632 CUSIP: 573874104 ISIN: US5738741041 LEI: - UEI: -
Secondary Listings
MRVL has no secondary listings inside our databases.